Key result
Elevated IL-1β linked to ~9% higher odds of in-hospital mortality in AMI patients.
Why the study?
The characteristics of systemic inflammatory responses in AMI and key inflammatory factors affecting prognosis were not well defined.
Does the inflammatory cytokine IL-1β predict in-hospital mortality in patients with acute myocardial infarction?
Cohort (n=146)
No
Does the inflammatory cytokine IL-1β predict in-hospital mortality in patients with acute myocardial infarction?
Odds Ratio: 1.093 (95% CI 1.019–1.172)
p-value: p=0.012
An acute, high-grade systemic inflammatory response occurs in AMI, with IL-1β serving as a novel and independent predictor for in-hospital mortality that matches the prognostic accuracy of the established GRACE score.
May refine AMI in-hospital mortality prediction; hypothesis-generating and requires prospective validation.
Purpose: Inflammation is a common pathway in acute or chronic cardiac injury. This study aimed to explore the characteristics of systemic inflammatory responses in acute myocardial infarction (AMI) and find the key inflammatory factors in the prognosis of AMI patients. Patients and Methods: A total of 146 patients with AMI and 468 patients with valvular heart disease (VHD) from West China Hospital of Sichuan University between January 2022 to September 2024 were included in this retrospective study using electronic medical records. Plasma cytokines (including IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17, interferon-α, interferon-γ, and tumor necrosis factor-α) were detected by flow cytometry within 24 hours of admission. Multivariate logistic regression analysis and survival analysis were conducted to identify factors independently associated with in-hospital mortality in AMI patients. Results: AMI patients exhibited an acute "high inflammatory status", characterized by markedly elevated Interleukin (IL)-6 and IL-10, compared with the low-grade inflammation in VHD (all P<0.001). The multivariate logistic regression model showed that except for the traditional risk factors (age, systolic blood pressure, and heart rate), IL-1β (odds ratio (OR)=1.093, 95% confidence intervals(CI): 1.019-1.172) remained an independent predictor of in-hospital mortality in AMI patients. The IL-1β-based model provided discrimination similar to the Global Registry of Acute Coronary Events Score (AUC 0.819 vs 0.812), and both scores demonstrated significant dose-response associations with mortality risk (IL-1β-based risk score: Hazard Ratio(HR) = 2.67 per SD, 95% CI: 1.82-3.90; GRACE score: HR = 2.66 per SD, 95% CI: 1.75-4.05). Conclusion: This study revealed that AMI triggered a high-grade systemic inflammatory status contrasted to that in VHD. Crucially, the upstream inflammatory mediator IL-1β was identified as an independent risk factor for in-hospital mortality in AMI patients. Whatever in the prognosis performance or risk assessment IL-1β-based risk score had the similar effects to GRACE score.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2026) conducted a cohort in Acute Myocardial Infarction (n=146). Interleukin-1β (IL-1β) levels vs. Lower IL-1β levels was evaluated on In-hospital mortality (OR 1.093, 95% CI 1.019-1.172, p=0.012). Elevated levels of the upstream inflammatory mediator IL-1β were independently associated with an increased risk of in-hospital mortality (OR 1.093) in patients with acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: